Alexandra Merz1, Amro Mohamed2, Cheyenne Corbett3, Kris Herring3, Jordan Hildenbrand2, Susan C Locke3, Steven Patierno3, Jesse Troy4, Steven Wolf4, S Yousuf Zafar3, Jack Chilcott5, Adam Higgins5, Hugo Manassei6, Colette McCoy5, Trudy L Buckingham5, Thomas W LeBlanc7,8. 1. Duke University, Durham, NC, 27710, USA. 2. Duke University School of Medicine, Durham, NC, 27710, USA. 3. Duke Cancer Institute, Durham, NC, 27710, USA. 4. Division of Biostatistics, Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, 27710, USA. 5. AstraZeneca, Wilmington, DE, 19803, USA. 6. Publicis Sapient, Cambridge, MA, USA. 7. Duke Cancer Institute, Durham, NC, 27710, USA. thomas.leblanc@duke.edu. 8. Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Box 2715, Durham, NC, 27710, USA. thomas.leblanc@duke.edu.
Abstract
PURPOSE: Mobile health interventions can improve patient care. We developed the Digital Supportive Care Awareness and Navigation (D-SCAN) application (app) to facilitate symptom monitoring and use/awareness of cancer supportive care resources. This study tested feasibility, usability/satisfaction, and preliminary efficacy of D-SCAN. METHODS: We randomized 50 patients with advanced cancer to receive the D-SCAN intervention or usual care; 10 caregivers also received D-SCAN. The primary feasibility outcome was determined by weekly symptom survey completion and end of study procedures. We assessed secondary outcomes including usability/satisfaction, awareness/use of supportive care resources, patient activation, and quality of life via various questionnaires including the Net Promoter Score (NPS), Patient Activation Measure (PAM-13), Functional Assessment of Cancer Therapy-General (FACT-G), and Caregiver Oncology Quality of Life (CarGOQOL) questionnaire. RESULTS: Seventy-six percent of intervention patients met feasibility criteria, exceeding our pre-determined threshold of 75%. Usability/satisfaction by NPS was high, at 14.3% and 12.5% for patients and caregivers, respectively. Intervention patient and caregiver resource awareness increased by a mean of 3.7 (p = 0.27) and 4.1 items, respectively. Supportive care resource utilization increased by a mean of 0.8 items for intervention patients (p = 0.70) and 0.6 for caregivers. PAM-13 increased by a mean of 1.6 for intervention patients (p = 0.65). FACT-G increased by a mean of 1.1 for intervention patients (p = 0.91), and CarGOQoL increased by a mean of 2.2 (p = 0.41). CONCLUSION: D-SCAN is a feasible, usable, and satisfactory intervention for augmenting patient and caregiver supportive care. Further testing is necessary to formally assess D-SCAN's efficacy and impact on patients and caregivers. CLINICAL TRIAL REGISTRATION NUMBER: NCT03628794. Registered on August 14th, 2018.
PURPOSE: Mobile health interventions can improve patient care. We developed the Digital Supportive Care Awareness and Navigation (D-SCAN) application (app) to facilitate symptom monitoring and use/awareness of cancer supportive care resources. This study tested feasibility, usability/satisfaction, and preliminary efficacy of D-SCAN. METHODS: We randomized 50 patients with advanced cancer to receive the D-SCAN intervention or usual care; 10 caregivers also received D-SCAN. The primary feasibility outcome was determined by weekly symptom survey completion and end of study procedures. We assessed secondary outcomes including usability/satisfaction, awareness/use of supportive care resources, patient activation, and quality of life via various questionnaires including the Net Promoter Score (NPS), Patient Activation Measure (PAM-13), Functional Assessment of Cancer Therapy-General (FACT-G), and Caregiver Oncology Quality of Life (CarGOQOL) questionnaire. RESULTS: Seventy-six percent of intervention patients met feasibility criteria, exceeding our pre-determined threshold of 75%. Usability/satisfaction by NPS was high, at 14.3% and 12.5% for patients and caregivers, respectively. Intervention patient and caregiver resource awareness increased by a mean of 3.7 (p = 0.27) and 4.1 items, respectively. Supportive care resource utilization increased by a mean of 0.8 items for intervention patients (p = 0.70) and 0.6 for caregivers. PAM-13 increased by a mean of 1.6 for intervention patients (p = 0.65). FACT-G increased by a mean of 1.1 for intervention patients (p = 0.91), and CarGOQoL increased by a mean of 2.2 (p = 0.41). CONCLUSION: D-SCAN is a feasible, usable, and satisfactory intervention for augmenting patient and caregiver supportive care. Further testing is necessary to formally assess D-SCAN's efficacy and impact on patients and caregivers. CLINICAL TRIAL REGISTRATION NUMBER: NCT03628794. Registered on August 14th, 2018.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Per Carlbring; Linda Maurin; Charlotta Törngren; Emma Linna; Thomas Eriksson; Elisabeth Sparthan; Marcus Strååt; Christian Marquez von Hage; Lise Bergman-Nordgren; Gerhard Andersson Journal: Behav Res Ther Date: 2010-10-15
Authors: Ethan Basch; Allison M Deal; Amylou C Dueck; Howard I Scher; Mark G Kris; Clifford Hudis; Deborah Schrag Journal: JAMA Date: 2017-07-11 Impact factor: 56.272
Authors: Doris Howell; Madeline Li; Rinku Sutradhar; Sumei Gu; Javaid Iqbal; Mary Ann O'Brien; Hsien Seow; Deborah Dudgeon; Clare Atzema; Craig C Earle; Carlo DeAngelis; Jonathan Sussman; Lisa Barbera Journal: Support Care Cancer Date: 2020-02-04 Impact factor: 3.603
Authors: Jihad S Obeid; Catherine A McGraw; Brenda L Minor; José G Conde; Robert Pawluk; Michael Lin; Janey Wang; Sean R Banks; Sheree A Hemphill; Rob Taylor; Paul A Harris Journal: J Biomed Inform Date: 2012-11-10 Impact factor: 6.317
Authors: Danny A Young-Afat; Carla H van Gils; David J Bruinvels; Carmen C van der Pol; Arjen J Witkamp; Sieta Sijtsema; Yvette Jonasse; Rhodé M Bijlsma; Margreet G Ausems; Annelies M Bos; Desirée H van den Bongard; Helena M Verkooijen Journal: JMIR Cancer Date: 2016-06-07